question for publication, I did not ask for their approval. They are totally innocent, and I can only hope that this letter serves to free them from any involvement in this matter.
On the other hand, this letter has also been easy to write. 1 realize that my behavior was both naive and careless, but my intent was not to deceive. In neither case were these publications submitted for peer review as representing new and original research. They were submitted, in the first instance, as part of a symposium issue, devoted to various aspects of sulfonylurea treatment, and, in the second case, as part of a review issue, focussed on various metabolic aspects of high blood pressure. The only reason to submit either article was my belief that it served a useful educational purpose. In the case of the acarbose paper, I was invited to participate in a symposium at the IDF meeting in Sydney. The symposium focussed on multiple aspects of the use of sulfonylurea compounds in the treatment of NIDDM. I was asked to review our experience with the combined use of sulfonylureas plus acarbose, and I did this, drawing on our results previously published in the Archives of Internal Medicine in 1984. A decision was made by the organizers of the Symposium to publish the proceedings, presumably based on the idea that a comprehensive review of these issues published in one journal edition would be useful. A private company was hired to aid in this process, and I submitted my manuscript directly to them. At that time I informed them that I had no copies of the figures for the planned article, and sent them a copy of the paper published in the Archives. I requested that new figures be generated, and that any attribution they felt necessary be obtained from the Archives. A considerable period elapsed between submission of the manuscript and return of the galleys to me. In proofing the galleys, I paid no attention as to whether attribution had been made to the Archives. I subsequently became acutely aware that nothing had been done. My lack of attention to detail does not rectify the omission, but it may help explain what might be considered inexplicable behavior on my part.
My behavior in the second instance of duplicate manuscripts was simply a function of naivete. I was asked to submit a manuscript for a review issue of Diabetes Care. Although the review in the American Journal of Medicine appeared only a short time before the one in Diabetes Care, it was written much earlier. The earlier review served as the basis for the one submitted to Diabetes Care, modified in order to improve it. For example, two new figures, containing unpublished data, were included in the Diabetes Care review. No attempt was made to convince anyone that the two reviews were basically different. If that were my goal, why would I have used almost identical titles for the two articles? Parenthetically, it should be noted that when I prepared the figures, in this instance, the attribution to earlier publications was made.
DIABETES CARE, VOLUME 15, NUMBER 8, AUGUST 1992 Publishing standards Before closing, I would like to comment as to my perception of the impact of my letter, and the editorial comments that will accompany it. Personally, once I am able to put these unpleasant events behind me, the experience will be liberating. I have always found it difficult to refuse a friend asking me to please plagiarize myself one more time for some enterprise they were organizing. Given my public chastisement, I will find it much easier in the future to decline such invitations. The fallout from these events may also have beneficial environmental effects. Editors of journals and/or pharmaceutical companies have an almost insatiable appetite to publish proceedings of meetings, symposia, reviews, etc. Although other investigators may have been more clever in masking the similarity of symposia and/or review articles that they have written, I truly doubt that I am the first to have committed the sin of publishing two such similar reviews. Having lived vicariously through me, and realizing the potential consequences of such behavior, I think it likely that their enthusiasm to participate in such efforts in the future will be dampened.
Although the publicity surrounding my transgression will provide me with more time in the future to focus on more personally useful pursuits, and may even save a few trees, I am not sure that the impact of this letter acknowledging my guilt, and the Editorials that will accompany it, will be entirely beneficial to the translation of potentially important new clinical information. More explicitly, those who receive Diabetes Care on a monthly basis would have had access to most of what I presented in the review issue of Diabetes Care if they had read the review article in the American Journal of Medicine. However, it is not so clear how many of these individuals would have ever seen that article. If you assume that the Editor who requested the review thought that the topic I addressed was an important one, that the information in the review was relevant to that topic, and that some significant proportion of the subscribers to Diabetes Care read the review, then the publication of a review similar to one previously published in another journal may not have been without pedagogical virtue. I think it highly likely that this kind of educational venture will be significantly diminished as the result of the publicity surrounding my activities. For all I know, such an outcome may be highly desirable, but I am not sure.
I am pleased that Diabetes Care intends "to invite a second editorial from an expert in the field of scientific publishing ethics to comment generally on the current lack of standards specifically relating to reviews and symposia proceedings and to suggest standards for proper conduct in publications such as this." However, I think these issues may not be as simple as it might appear. For example, a good review article is not simply a summary of published data, but a reflection of an individual's creative efforts to present a coherent view of an often complex scientific issue. As such, it is likely that a given individual will approach the same problem in a similar fashion, obviously modified over time by new information. Given this perspective, once having reviewed an area, it is very likely that any subsequent effort will closely resemble the original creative effort. (In this context, I should emphasize that I am thinking of the intellectual thrust of the review, not how the words are arranged.) If this is the case, at what point does the intellectual content of the subsequent review article differ enough from the original to be acceptable? Fifty percent? Seventy-five per cent? Judged by whom? I don't believe this is a simple matter, and I, for one, will certainly opt in the future to err by omission. Will this foster educational goals? I wonder?
In conclusion, I am guilty as charged. I am truly sorry for any deleterious effect that my behavior has had on my co-authors, Diabetes Care, or the American Diabetes Association. I have learned a great deal from this episode, and I can only hope that the discussion that follows this disclosure will also be beneficial to fellow investigators who are asked to contribute to symposium proceedings and/or prepare reviews for publication.
